Gout: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• NLRP3 1
• SGLT2 0
• GLP-1 1
• AMPK 1
• NRF2 0
• SIRT1 0
• AKT 0
• COX-2 0
• IL-17 0
• MAPK 0
• mTOR 0
• PCSK9 0
• PI3K 0
• TNF 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Nanoscale imaging of living cells by liquid phase electron microscopy (LivEM)

  Stichting Radboud Universitair Medisch Centrum· Nijmegen, Hollandia· EU contribution 217 076 EUR· until 2028. dec.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-EIC

  Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 4 323 351 EUR· until 2028. aug.· 5 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  Unraveling the molecular mechanisms underlying intracellular crystal formation (CRYSTALCELL)

  Weizmann Institute of Science· Rehovot, Izrael· EU contribution 1 500 000 EUR· until 2027. nov.

  The disease is named only in the funder's project summary, not in the title.

3 of 3 running projects, newest first. Listed amounts together: 6,0 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 3
• Organoids 2
• Mendelian Randomization Analysis 33
• CRISPR-Cas Systems 1
• Gene Expression Profiling 9
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 3
• Proteomics 10
• Metabolomics 18
• Flow Cytometry 1
• Immunohistochemistry 1
• Xenograft Model Antitumor Assays 1
• Magnetic Resonance Imaging 8
• Machine Learning 14
• Deep Learning 1
• Cohort Studies 22
• Genome-Wide Association Study 29

• Genome-Wide Association Study of Kidney Function Decline in ~100 000 Taiwanese Adults-A Taiwan Biobank Cohort.

  Nephrology (Carlton), 2026. nov.

• Uncovering metabolite-inflammatory protein interactions in gout pathogenesis: A 2-sample bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. okt.

• Genetic evidence linking gout to increased risk of epilepsy: A two-sample Mendelian randomization study.

  Adv Clin Exp Med, 2026. okt.

• Causal determinants of gout in 614,000 adults: A two-sample Mendelian randomization study of dietary, lifestyle, and metabolic traits.

  Medicine (Baltimore), 2026. szept.

• Phenome- and laboratory-wide meta-analyses of sickle cell trait reveal multi-system disease associations.

  Am J Hum Genet, 2026. szept.

• Investigating the causal role of smoking in gout: A triangulation approach combining NHANES data, genetic correlation, and Mendelian randomization.

  Medicine (Baltimore), 2026. aug.

• Construction and Validation of Plasma Protein-Based Musculoskeletal Biological Age and Genetic and Environmental Risk Profiles.

  Aging Cell, 2026. aug.

• Genome-wide association study identifies toll-like receptor four protein-mediated metabolic remodelling affecting gout pathogenesis.

  J Glob Health, 2026. júl.

• Genetic susceptibility to uric acid and selected cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies.

  Front Endocrinol (Lausanne), 2026. júl.

• The causal associations of serum uric acid levels and gout with the risk of acute pancreatitis: A bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. júl.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.